ATLANTA, 1 de noviembre de 2022 /PRNewswire/ — Polyvision Corporation, líder global en innovación y fabricación de CeramicSteel, productos de escritura colaborativa y paneles arquitectónicos para revestimientos interiores y exteriores, anunció hoy que ha ascendido a Kevin Taney como…
Related Posts
CalWave Successfully Concludes Historic Wave Energy Pilot in California
OAKLAND, Calif., Sept. 1, 2022 /PRNewswire/ — CalWave (“CalWave Power Technologies, Inc.”), a leader in wave energy development, has successfully…
Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.
Pharma Desk, India: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ivabradine Tablets, 5 mg and 7.5 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Corlanor Tablets, 5…
Read More “Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.” »
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
STANDEX ANNOUNCES TIMING OF FIRST QUARTER FISCAL 2023 RESULTS
SALEM, N.H., Oct. 28, 2022 /PRNewswire/ — Standex International Corporation (NYSE: SXI) will announce its first quarter fiscal 2023 financial…